Related Experiment Video

Updated: May 25, 2026

Electrochemiluminescence Assays for Human Islet Autoantibodies
09:15

Electrochemiluminescence Assays for Human Islet Autoantibodies

Published on: March 23, 2018

Islet autoantibodies and residual beta cell function in type 1 diabetes children followed for 3-6 years

J S Sorensen1, F Vaziri-Sani, M Maziarz

  • 1Department of Pediatrics, Aarhus University Hospital, Skejby, DK-8200 Aarhus N, Denmark.

Diabetes Research and Clinical Practice
|January 19, 2012
PubMed

Insights

Age at diagnosis is key for predicting residual beta-cell function in type 1 diabetes (T1D). Declining islet autoantibodies like IA-2A and ZnT8A after diagnosis may also indicate reduced function.

Area of Science:

  • Endocrinology
  • Immunology
  • Pediatrics

Background:

  • Type 1 diabetes (T1D) is an autoimmune disease characterized by the destruction of insulin-producing beta cells in the pancreas.
  • Residual beta-cell function (RBF) plays a crucial role in glycemic control and long-term T1D management.
  • Predicting RBF is essential for personalized treatment strategies and understanding disease progression.

Purpose of the Study:

  • To investigate the predictive value of islet autoantibodies at diagnosis and during the early years of T1D for subsequent residual beta-cell function.
  • To determine the association between specific autoantibodies (GAD65, IA-2, ZnT8R, ZnT8W, ZnT8Q) and RBF in children with T1D.

Main Methods:

  • A cohort of 260 children diagnosed with T1D was studied.
  • Islet autoantibodies were measured at diagnosis and 3-6 years post-diagnosis.
  • Fasting and stimulated residual beta-cell function were assessed 3-6 years after diagnosis.

Main Results:

  • Older age at T1D diagnosis significantly increased the likelihood of detectable fasting and stimulated C-peptide levels years later.
  • Decreases in IA-2 autoantibody (IA-2A) levels were associated with a higher chance of detectable C-peptide.
  • Reductions in ZnT8W and ZnT8Q autoantibody levels also correlated with preserved RBF, while GAD65 and ZnT8R autoantibodies showed no significant association.

Conclusions:

  • Age at diagnosis is the primary predictor of sustained residual beta-cell function in T1D.
  • Changes in specific islet autoantibody levels, particularly IA-2A and possibly ZnT8A, between diagnosis and follow-up may reflect alterations in beta-cell function.
Abstract

More Related Videos

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice10:03

Bioluminescent Monitoring of Graft Survival in an Adoptive Transfer Model of Autoimmune Diabetes in Mice

Published on: November 18, 2022

Isolation of Human Islets from Partially Pancreatectomized Patients11:10

Isolation of Human Islets from Partially Pancreatectomized Patients

Published on: July 30, 2011

Related Concept Videos

Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...
Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...